1. Are We Closer to Personalized Medicine in MS?

3. Disclaimers

4. Program Goals

5. What Is Personalized Medicine?

6. What Is Personalized Medicine? (cont)

7. Prognostic Indicators

8. Biomarkers: JC Virus Antibody Index

9. Biomarkers

10. Patient Factors

11. Drug Factors

12. Assessing Risk

13. Experience With MS Drugs: Clinical Practice vs Clinical Trials

14. Monitoring Response

15. Monitoring Response: Modified Rio Score

16. Monitoring Response (cont)

17. Switching and Sequencing Therapy

18. Risk Stratification at Diagnosis -- and Beyond

19. On the Horizon: Agents in Development

20. On the Horizon: Reduced Injections

21. Summary and Key Points

22. Abbreviations

23. References

24. References (cont)

25. References (cont)

26. References (cont)

27. References (cont)